The Second <i>Candida auris</i> Isolate from Aural Discharge in Japan

Abstract

Candida is one of the most common causative agents of mycoses identified in autopsy cases in Japan (1). Candidosis is known as a hospital-acquired infection which is sometimes refractory. Candida auris is a rapidly emerging, life-threatening, fungal pathogen that is difficult to identify and shows multi-antifungal drug resistance (MDR). C. auris was first identified in 2009 from the external ear canal discharge of a patient admitted to a hospital in Japan (2). However, for reasons that remain unclear, it has not since been isolated in Japan. Meanwhile, C. auris has been identified and reported in other countries, including South Korea, India, Venezuela, the USA, Colombia, the UK, South Africa, Kuwait, Pakistan, Kenya, and Israel (3).